Xenetic Biosciences Inc

NASDAQ:XBIO 11:59:44 AM EDT

3.35

+0.13 (+4.04%)

4:07:40 PM EDT: $3.30 -0.05 (-1.49%)

Market Cap (Intraday)	5.16M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.68 Million
Adjusted EPS	-$0.87

See more estimates

10-Day MA	$3.16
50-Day MA	$3.80
200-Day MA	$3.96

See more pivots

Xenetic Biosciences Inc Stock, NASDAQ:XBIO

945 Concord Street, Suite 102, Framingham, Massachusetts 01701

United States of America

Phone: +1.781.778.7720

Number of Employees: 4

http://www.xeneticbio.com

Description

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patientÃ¢â?¬â?¢s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.